Salt Lake City, UT, United States of America

Daniel Lambert

This inventor holds 1 USPTO granted patent. Top assignee: Pathology Watch Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Lambert. Retrieved from https://idiyas.com/inventor/daniel-lambert-4hchcvhr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Daniel Lambert and Neural-Network Approaches to Melanoma Pathology

Introduction

Daniel Lambert is an inventor based in Salt Lake City, Utah, whose patent work concerns the use of neural networks in melanoma pathology. His disclosed invention combines molecular information from a patient biopsy with image analysis to generate a prognosis.

Latest Patents

Lambert is associated with 1 patent: “Systems, Methods, and Devices for Melanoma Pathology Using One or More Neural Networks.” The described techniques receive molecular and image data corresponding to a patient’s biopsy sample. They encode the molecular data using a selected scheme, process the image data with an image-analysis neural network, and concatenate the encoded molecular data with image data at an intermediate network layer. The network then uses the combined information to produce a prognosis output.

Career Highlights

Lambert’s patent work reflects an approach to pathology that integrates molecular data and medical-image analysis. The invention describes how these complementary sources of information can be combined within a neural network to support melanoma prognosis.

Collaborations

Lambert is associated with Pathology Watch Inc. His listed coworkers include James Requa and Jeffery Hester.

Conclusion

Daniel Lambert’s patent describes a neural-network system that combines biopsy-related molecular and image data to produce a melanoma prognosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…